cbdMD, Inc. (YCBD) |
|
0.763 0.08 (11.78%)
|
05-18 01:50 |
|
Open: |
0.7167 |
Pre. Close: |
0.6826 |
|
High:
|
0.88 |
Low:
|
0.71 |
|
Volume:
|
386,347 |
Market Cap:
|
45(M) |
|
|
|
|
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.88 - 0.88 |
0.88 - 0.89 |
|
Low:
|
0.7 - 0.71 |
0.71 - 0.71 |
|
Close:
|
0.76 - 0.76 |
0.76 - 0.77 |
|
Technical analysis |
as of: 2022-05-17 4:51:26 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 1.02  One year: 1.2 |
| Support: |
Support1: 0.67 Support2: 0.55 |
| Resistance: |
Resistance1: 0.87 Resistance2: 1.02 |
| Pivot: |
0.67 |
| Moving Average: |
MA(5): 0.7 MA(20): 0.68
MA(100): 0.88  MA(250): 1.67 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 70.2 %D(3): 61.5 |
| RSI: |
RSI(14): 52.7 |
| 52-week: |
High: 3.47 Low: 0.55 |
| Average Vol(K): |
3-Month: 267 (K) 10-Days: 171 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ YCBD ] has closed below upper band by 8.7%. Bollinger Bands are 28.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 17 May 2022
cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha
Thu, 05 May 2022
Should You Buy cbdMD Inc (YCBD) Stock on Thursday? - InvestorsObserver
Tue, 26 Apr 2022
Can cbdMD Inc (YCBD) Stock Rise to the Top of Healthcare Sector Tuesday? - InvestorsObserver
Thu, 03 Mar 2022
cbdMD expands product offering with retail partner GNC (NYSE:YCBD) - Seeking Alpha
Tue, 22 Feb 2022
cbdMD Requests the Food and Drug Administration (FDA) Remove the Drug Exclusion for CBD and Review cbdMD’s Extensive Safety Submission - Yahoo Finance
Fri, 18 Feb 2022
These Pot Stocks Made Major International Moves This Week - Schaeffers Research
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
58 (M) |
| Shares Float |
39 (M) |
|
% Held by Insiders
|
32.1 (%) |
|
% Held by Institutions
|
22.3 (%) |
|
Shares Short
|
2,070 (K) |
|
Shares Short P.Month
|
1,020 (K) |
Stock Financials |
|
EPS
|
-0.48 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.77 |
|
Profit Margin (%)
|
-52.6 |
|
Operating Margin (%)
|
-44.1 |
|
Return on Assets (ttm)
|
-10.4 |
|
Return on Equity (ttm)
|
-25.7 |
|
Qtrly Rev. Growth
|
-16.3 |
|
Gross Profit (p.s.)
|
0.51 |
|
Sales Per Share
|
0.76 |
|
EBITDA (p.s.)
|
-0.32 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-14 (M) |
|
Levered Free Cash Flow
|
-7 (M) |
Stock Valuations |
|
PE Ratio
|
-1.62 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.42 |
|
Price to Sales
|
0.99 |
|
Price to Cash Flow
|
-3.16 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
